0 results for 'Wachtell, Lipton, Rosen'
Cravath Enters Modern Era of Big Law Amid Regular Rate of Partner Exits
"The tweaking of their model may have stopped some people from leaving, but they don't seem to be leveraging the other aspect of breaking lockstep to expand and grow," noted one observer.Deal Watch: Debt Offerings Surge as Markets Begin to Turn
"It is booming right now," said Wachtell partner John Sobolewski of the liability management market.Pressure on UK Law Firms as US Competitors Raise NQ Pay Again
As US firms match the Cravath scale, domestic UK firms will fear falling too far behind.Corporate Governance Update: A Formative Period for AI Regulation
With the issuance in October 2023 of a wide-ranging executive order on artificial intelligence, the Biden administration took its most significant action to date toward oversight of the development and use of AI technologies. In the absence of Congressional action in this area, the order represents a step toward laying the groundwork for future federal regulatory action by a broad swath of agencies and departments.Your Clients Are Leaving Without Telling You: The Morning Minute
The news and analysis you need to start your day.View more book results for the query "Wachtell, Lipton, Rosen "
Deal Watch: Big Week in Multiple Verticals in M&A
Skadden and Paul Weiss had multiple big deals in the last few days, as deals from tech, energy and PE power the week. And there were four new IPOs.Willkie Farr Taps Bay Area Gibson Dunn Partner to Help Lead White-Collar Practice
Michael Li-Ming Wong is departing Gibson Dunn after more than 12 years at the firm.Deal Watch: Kirkland, Akin Drive Energy Deals as Big Law Leans Into Sector for M&A
Four of the five announced M&A deals of more than $1 billion in the past week involved the energy and infrastructure sectors.Majority owner's intentional acts to remove founders from the company to eliminate their right to designate board members materially interfered with those rights in violation of the parties' stockholders' agreement's "reasonable efforts" clause.
Deal Watch: Cravath, Skadden, Shearman, K&L Gates Steer Health Care Deals Amid Industry Momentum
"We are cautiously optimistic the healthcare and pharma IPO market will gain strength in 2024," said McDermott partner Todd Kornfeld.State AI Legislation Is on the Move in 2024
Brought to you by LexisNexis®
Download Now
2024 ESI Risk Management & Litigation Readiness Report
Brought to you by Pagefreezer
Download Now
Creating a Culture of Compliance
Brought to you by Ironclad
Download Now
A Buyer's Guide to Law Firm Software
Brought to you by PracticePanther
Download Now